Good sleep is essential for overall health, yet around 30-40% of adults report experiencing sleep disturbances or insomnia following the COVID-19 pandemic, a significant increase from pre-pandemic levels of 8.5%. Certain populations have been disproportionately affected, including those who contracted COVID-19 (52%), children and adolescents (45%), and healthcare workers (42%). Sleep problems have persisted for weeks to months post-recovery, with disturbances such as insomnia, frequent waking, breathing difficulties, vivid dreams, and nightmares.

 

Young adults (ages 18-29) and women have reported higher rates of sleep disturbances, with 40% of young adults and 36% of women affected, compared to 28% of men. Sleep disorders, whether short-term or chronic, can worsen existing mental health conditions and contribute to declines in overall well-being.

 

Neurofeedback helps regulate sleep by targeting brain areas responsible for controlling sleep and wake cycles. By adjusting brainwaves related to sleep and arousal, neurofeedback can normalize sleep patterns. Research shows that neurofeedback enhances the brain's ability to regulate sleep, helping individuals experience more restful, uninterrupted sleep. Unlike medication, neurofeedback has minimal side effects, with tiredness being the most commonly reported.